These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33253591)

  • 1. High-Contrast CXCR4-Targeted
    Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
    Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 PET imaging of mantle cell lymphoma using [
    Mayerhoefer ME; Raderer M; Lamm W; Pichler V; Pfaff S; Weber M; Kiesewetter B; Hacker M; Kazianka L; Staber PB; Wester HJ; Rohrbeck J; Simonitsch-Klupp I; Haug A
    Theranostics; 2021; 11(2):567-578. PubMed ID: 33391493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
    Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ
    Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.
    Zhang XX; Sun Z; Guo J; Wang Z; Wu C; Niu G; Ma Y; Kiesewetter DO; Chen X
    Mol Imaging Biol; 2013 Dec; 15(6):758-67. PubMed ID: 23636490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
    Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
    Kuo HT; Pan J; Lau J; Zhang C; Zeisler J; Colpo N; Bénard F; Lin KS
    Mol Pharm; 2017 Mar; 14(3):821-829. PubMed ID: 28094956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second generation Al
    Spahn MA; Luyten K; Van Loy T; Sathekge M; Deroose CM; Koole M; Schols D; Vanduffel W; De Vos K; Annaert P; Bormans G; Cleeren F
    Nucl Med Biol; 2024; 132-133():108906. PubMed ID: 38518400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Metal-Free DOTA-Conjugated
    Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
    Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of CXCR4 expression using [
    Cheng K; Wang S; Liu T; Pei J; Wang S; Liu J; Zhao K; Luo Y; Xu S; Yu J; Liu J
    Theranostics; 2024; 14(16):6337-6349. PubMed ID: 39431004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
    Vag T; Gerngross C; Herhaus P; Eiber M; Philipp-Abbrederis K; Graner FP; Ettl J; Keller U; Wester HJ; Schwaiger M
    J Nucl Med; 2016 May; 57(5):741-6. PubMed ID: 26769866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of an
    Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma Imaging Using
    Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
    Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Amor-Coarasa A; Kelly JM; Singh PK; Ponnala S; Nikolopoulou A; Williams C; Vedvyas Y; Jin MM; Warren JD; Babich JW
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31022852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.
    Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4.
    Yang T; Shi D; Lin Q; Shen H; Tan H; Liu Y; Shi H; Cheng D
    Mol Pharm; 2024 May; 21(5):2415-2424. PubMed ID: 38606663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
    Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
    Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of tumor CXCR4 expression with 4-18F-T140.
    Jacobson O; Weiss ID; Kiesewetter DO; Farber JM; Chen X
    J Nucl Med; 2010 Nov; 51(11):1796-804. PubMed ID: 20956475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging.
    Pourghiasian M; Liu Z; Pan J; Zhang Z; Colpo N; Lin KS; Perrin DM; Bénard F
    Bioorg Med Chem; 2015 Apr; 23(7):1500-6. PubMed ID: 25757604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4-directed PET/CT with [
    Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.